BioSpace News Archive

Over 600,000 Overnight Accommodations Provided To Critically Ill Children and Their Families Since 1993

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2™ Insulin Pump with Basal-IQ™ Technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events (hypoglycemia).

Technavio has announced their latest pipeline analysis report on the drug pipeline for dry age-related macular degeneration.

Darryl Williams, MediSpend’s senior director analytics, will moderate a panel of leading pharmaceutical experts in a discussion of the varying degrees of analytics programs across the life sciences industry at the 12th Annual Forum on Transparency and Aggregate Spend at 2:50pm on Tuesday, August 21, 2018 in Washington, DC.

The Medical Science Liaison Society (MSL Society), the only 501(c)(3) non-profit organization exclusively dedicated to advancing the global medical science liaison (MSL) profession, has announced the finalists for the first-ever MSL of the Year Awards.

Chardan announced that the firm acted as sole placement agent in Krystal Biotech, Inc.'s (NASDAQ: KRYS) securities purchase agreement with Frazier Healthcare Partners for the private placement of 625,000 shares at $16 per share. The private placement will yield gross proceeds of $10 million.

Continuing its track record as an innovator in in flow cytometry, today, ACEA Biosciences released the most advanced benchtop flow cytometer on the market. The NovoCyte Quanteon flow cytometer builds upon its wildly successful predecessor, the NovoCyte, to provide an expanded set of capabilities that easily accommodates the large, multi-color panels found in today’s highly progressive flow cytometry laboratories.

With the goal of improving the antimicrobial drug discovery process, scientists in Finland will employ xCELLigence technology to identify compounds active against E. coli biofilms.

Shares Original Song “Stand Up For Yourself” Franklin Recorded in 2007

ACEA Biosciences is a privately owned biotechnology company which develops cutting edge instrumentation for cell analysis. The company has just introduced the xCELLigence RTCA S16, which is the ideal entry level model for exploratory studies in cell biology.